When to reach for it
In the EP lab, transcutaneous pacing is used for short windows where the patient needs an external pacemaker right now, before transvenous pacing can be established or while a definitive solution is being prepared. The most common scenarios:
- Profound vagal-induced bradycardia or asystole during a case (e.g., transseptal puncture, contrast injection, manipulation of the AV nodal region) that hasn’t responded to atropine and fluid
- Iatrogenic complete heart block during AV-nodal ablation, septal RF, or aggressive His-region manipulation — pacing while the situation is assessed for permanent pacemaker need
- Inadvertent temporary pacing-wire dislodgement during generator change or case manipulation
- Severe symptomatic bradycardia developing during a case in a patient who didn’t have a wire in yet
The pads should already be in place — every EP lab patient has external defibrillator pads on at case start, and those same pads pace.
Setting it up
Most modern defibrillators have a pacing mode. Workflow:
- Confirm pads are on and connected. Anterolateral position is standard. If an implanted device is over the anterior pad position, switch to antero-posterior.
- Switch the defibrillator to pacer mode. The exact UI varies — Zoll, Philips, Stryker (Physio-Control), and Mindray each have a different button sequence. The team should drill this monthly.
- Select rate. Start at 60–80 bpm for adults. Faster rates worsen pain tolerance and don’t usually help hemodynamics.
- Select mode. Demand mode (synchronized to patient’s own beats) is preferred when there is any intrinsic activity. Asynchronous (fixed-rate) is used only when there is no detectable intrinsic rhythm.
- Start output low — 30–50 mA — and increase in 10 mA increments until capture. Most adults capture at 50–100 mA. Larger patients, thicker chest walls, or pads placed over devices may need more.
- Confirm capture — see below.
- Sedate. Most awake patients need sedation to tolerate the pacing. Midazolam 1–2 mg IV ± fentanyl 25–50 µg IV titrated to comfort while preserving airway.
- Set output 10–20 mA above the capture threshold for a safety margin.
Confirming capture — the critical step
The single most common mistake in transcutaneous pacing is assuming capture when there isn’t. The pacing spike on the monitor is a visual artifact regardless of whether the heart actually contracted. Real capture requires both:
- Electrical capture: a wide paced QRS complex immediately following each pacing spike on the monitor. Look for a consistent, time-locked relationship between spike and QRS, and a paced morphology (typically LBBB-like since the pads pace from the chest wall in).
- Mechanical capture: a palpable pulse (femoral preferred — radial can be unreliable with chest-wall muscle contraction artifact) timed to the paced beats, or a measurable blood pressure during pacing, or visible wall motion on ICE/echo.
If you have electrical capture without mechanical capture, the pacer is firing but the heart is not pumping. This is failure. Increase output, reposition pads, or escalate.
When pacing isn’t working
If captures aren’t happening despite reasonable output, the troubleshooting steps in order:
- Increase output — many adults need 100+ mA; large patients sometimes need 150–200 mA
- Reposition pads — antero-posterior often captures when anterolateral doesn’t
- Verify connections — pads adherent, cables fully seated, pacer mode actually engaged
- Verify pads are over heart muscle — not over a bony prominence, not too low (over diaphragm), not too high (over clavicle)
- Check for a wet skin barrier — sweat or gel migration can short the current
- Escalate to transvenous — if the situation allows, do not waste minutes trying to make transcutaneous work when a wire is the answer
Pain management
This is genuinely uncomfortable for awake patients — chest-wall muscle contractions with every paced beat. For a brief bridge (<5 minutes), most patients can tolerate it with reassurance. For longer windows, plan sedation:
- Midazolam 1–2 mg IV, repeated as needed
- Fentanyl 25–50 µg IV, titrated
- Propofol boluses (10–30 mg) for the deeply uncomfortable patient — but watch for hypotension on top of an already compromised hemodynamic state
If you have a patient who is bradycardic, hypotensive, and now needs heavy sedation for transcutaneous pacing, you are buying minutes — escalate to transvenous pacing without delay.
Escalating to transvenous pacing
Transcutaneous pacing should not be the long-term answer. Plan for transvenous pacing within 30 minutes if:
- The underlying problem is unlikely to resolve quickly (post-AV node ablation, structural conduction system disease)
- The patient needs sedation to tolerate pacing
- Skin pad-site burns are starting (visible erythema at pad margins is the warning sign)
- The patient is awake and uncomfortable
A transvenous wire — either via femoral, jugular, or subclavian access — is faster, more reliable, more comfortable, and can be left for 24–72 hours while definitive plans are made.
Common scenarios in the EP lab
Vagal asystole during transseptal
Atropine 0.5–1 mg IV usually fixes this within seconds. If not, transcutaneous pacing for the 30–60 second window of asystole — sedation usually isn’t needed because the patient is unconscious or already sedated. Most recover spontaneously.
Iatrogenic complete heart block during AV-node ablation
Expected if the ablation was intentional (e.g., AVN ablation for rapid AF in a pacemaker patient). Unexpected if the case was supposed to spare the AV node. Either way: transcutaneous pacing as the bridge to either an existing pacemaker takeover, a transvenous wire, or — in the unintended-block case — emergent permanent pacemaker placement.
Post-procedure bradycardia in recovery
Less common but does happen. Vagal reaction to mobilization, post-anesthetic bradycardia, or worsened underlying conduction disease. The pads come off in recovery so transcutaneous pacing requires reapplying them; consider a transvenous wire if recurrent.